News Image

Citius Oncology Expands LYMPHIRâ„¢ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim

Provided By PR Newswire

Last update: Dec 4, 2025

Partnership expands access to LYMPHIR for patients with cutaneous T-cell lymphoma across Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia, and the UAE

Read more at prnewswire.com

CITIUS ONCOLOGY INC

NASDAQ:CTOR (12/12/2025, 8:23:14 PM)

After market: 1.13 0 (0%)

1.13

0 (0%)


CITIUS PHARMACEUTICALS INC

NASDAQ:CTXR (12/12/2025, 8:23:16 PM)

After market: 1.13 +0.01 (+0.89%)

1.12

-0.04 (-3.45%)



Find more stocks in the Stock Screener

CTOR Latest News and Analysis

Follow ChartMill for more